EC Number   |
Disease |
PubMed ID |
Title of Publication  |
Category |
Confidence Level |
|---|
   4.6.1.18 | Neoplasms |
21223552 |
A human ribonuclease induces apoptosis associated with p21WAF1/CIP1 induction and JNK inactivation. |
therapeutic application
unassigned |
4
0 |
| 4.6.1.18 | Leukemia |
26605343 |
A Humanized Anti-CD22-Onconase Antibody-Drug Conjugate Mediates Highly Potent Destruction of Targeted Tumor Cells. |
ongoing research
unassigned |
2
0 |
| 4.6.1.18 | Lymphoma |
26605343 |
A Humanized Anti-CD22-Onconase Antibody-Drug Conjugate Mediates Highly Potent Destruction of Targeted Tumor Cells. |
ongoing research
unassigned |
2
0 |
| 4.6.1.18 | Inflammatory Bowel Diseases |
12135031 |
A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease. |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
1
2
0 |
| 4.6.1.18 | Mesothelioma, Malignant |
18606715 |
A novel combination: ranpirnase and rosiglitazone induce a synergistic apoptotic effect by down-regulating Fra-1 and Survivin in cancer cells. |
causal interaction
ongoing research
therapeutic application
unassigned |
1
4
3
0 |
| 4.6.1.18 | Neoplasms |
18606715 |
A novel combination: ranpirnase and rosiglitazone induce a synergistic apoptotic effect by down-regulating Fra-1 and Survivin in cancer cells. |
causal interaction
ongoing research
therapeutic application
unassigned |
1
4
3
0 |
| 4.6.1.18 | Breast Neoplasms |
27894092 |
A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapy. |
diagnostic usage
ongoing research
unassigned |
3
3
0 |
| 4.6.1.18 | Breast Neoplasms |
26502078 |
A Novel Ribonuclease from Rana Chensinensis and Its Potential for the Treatment of Human Breast Cancer. |
causal interaction
ongoing research
therapeutic application
unassigned |
2
3
4
0 |
| 4.6.1.18 | Neoplasms |
26502078 |
A Novel Ribonuclease from Rana Chensinensis and Its Potential for the Treatment of Human Breast Cancer. |
causal interaction
ongoing research
therapeutic application
unassigned |
2
3
4
0 |
| 4.6.1.18 | Infections |
27527084 |
A novel RNase 3/ECP peptide for Pseudomonas aeruginosa biofilm eradication. Combining antimicrobial, lipopolysaccharide binding and cell agglutinating activities. |
unassigned |
0 |
